MP
Mangrove Partners’s ANI Pharmaceuticals ANIP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-426,162
| Closed | -$17.4M | – | 49 |
|
|
2020
Q1 | $17.4M | Buy |
426,162
+99,384
| +30% | +$4.05M | 2.39% | 12 |
|
|
2019
Q4 | $20.2M | Sell |
326,778
-183,174
| -36% | -$11.3M | 2.95% | 11 |
|
|
2019
Q3 | $37.2M | Sell |
509,952
-39,449
| -7% | -$2.88M | 4.5% | 6 |
|
|
2019
Q2 | $45.2M | Hold |
549,401
| – | – | 5.11% | 4 |
|
|
2019
Q1 | $38.8M | Hold |
549,401
| – | – | 5.18% | 5 |
|
|
2018
Q4 | $24.7M | Buy |
549,401
+37,000
| +7% | +$1.67M | 3.29% | 7 |
|
|
2018
Q3 | $29M | Buy |
512,401
+115,478
| +29% | +$6.53M | 1.83% | 6 |
|
|
2018
Q2 | $26.5M | Buy |
396,923
+20,609
| +5% | +$1.38M | 1.71% | 9 |
|
|
2018
Q1 | $21.9M | Hold |
376,314
| – | – | 1.43% | 11 |
|
|
2017
Q4 | $24.3M | Hold |
376,314
| – | – | 3.27% | 11 |
|
|
2017
Q3 | $19.8M | Buy |
376,314
+96,448
| +34% | +$5.06M | 3.39% | 11 |
|
|
2017
Q2 | $13.1M | Buy |
279,866
+221,491
| +379% | +$10.4M | 2.67% | 12 |
|
|
2017
Q1 | $2.89M | Buy |
+58,375
| New | +$2.89M | 0.66% | 18 |
|